| Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ... AIDS research and human retroviruses 18 (12), 835-838, 2002 | 184 | 2002 |
| Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients M Zaccarelli, V Tozzi, P Lorenzini, MP Trotta, F Forbici, ... Aids 19 (10), 1081-1089, 2005 | 172 | 2005 |
| Efficacy of cerebrospinal fluid (CSF)–penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma A Antinori, CF Perno, ML Giancola, F Forbici, G Ippolito, RM Hoetelmans, ... Clinical Infectious Diseases 41 (12), 1787-1793, 2005 | 153 | 2005 |
| Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy CF Perno, A Cozzi-Lepri, C Balotta, F Forbici, M Violin, A Bertoli, G Facchi, ... The Journal of infectious diseases 184 (8), 983-991, 2001 | 117 | 2001 |
| Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ... Journal of virology 80 (14), 7186-7198, 2006 | 99 | 2006 |
| Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure F Ceccherini-Silberstein, F Erba, F Gago, A Bertoli, F Forbici, ... Aids 18 (12), 11-19, 2004 | 88 | 2004 |
| Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to … F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ... Journal of virology 81 (20), 11507-11519, 2007 | 85 | 2007 |
| Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ... Clinical infectious diseases 58 (8), 1156-1164, 2014 | 83 | 2014 |
| Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences C Balotta, G Facchi, M Violin, S Van Dooren, A Cozzi-Lepri, F Forbici, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 27 (5), 499-505, 2001 | 82 | 2001 |
| Virologic correlates of adherence to antiretroviral medications and therapeutic failure CF Perno, F Ceccherini-Silberstein, A De Luca, A Cozzi-Lepri, C Gori, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S118-S122, 2002 | 66 | 2002 |
| Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome V Tozzi, M Zaccarelli, S Bonfigli, P Lorenzini, G Liuzzi, MP Trotta, F Forbici, ... Antiviral therapy 11 (5), 553-560, 2006 | 62 | 2006 |
| Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes S Aquaro, S Panti, MC Caroleo, E Balestra, A Cenci, F Forbici, G Ippolito, ... Journal of leukocyte biology 68 (3), 429-435, 2000 | 62 | 2000 |
| Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation CF Perno, A Cozzi-Lepri, C Balotta, A Bertoli, M Violin, L Monno, T Zauli, ... Aids 16 (4), 619-624, 2002 | 54 | 2002 |
| Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed CF Perno, A Cozzi-Lepri, F Forbici, A Bertoli, M Violin, MS Mura, G Cadeo, ... The Journal of infectious diseases 189 (11), 1983-1987, 2004 | 49 | 2004 |
| Impact of pre-therapy viral load on virological response to modern first-line HAART MM Santoro, D Armenia, C Alteri, P Flandre, A Calcagno, M Santoro, ... Antiviral therapy 18 (7), 867-876, 2013 | 48 | 2013 |
| Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay A Casabianca, C Gori, C Orlandi, F Forbici, CF Perno, M Magnani Molecular and Cellular Probes 21 (5-6), 368-378, 2007 | 47 | 2007 |
| Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010 | 45 | 2010 |
| Subtype analysis and mutations to antiviral drugs in HIV‐1‐infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme MC Bellocchi, F Forbici, L Palombi, C Gori, E Coelho, V Svicher, ... Journal of medical virology 76 (4), 452-458, 2005 | 45 | 2005 |
| Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz … V Tozzi, M Zaccarelli, P Narciso, MP Trotta, F Ceccherini-Silberstein, ... The Journal of infectious diseases 189 (9), 1688-1695, 2004 | 44 | 2004 |
| Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA M Zaccarelli, MM Santoro, D Armenia, V Borghi, W Gennari, C Gori, ... Journal of Clinical Virology 82, 94-100, 2016 | 40 | 2016 |
